Skip to main content
Signal8

PepGen Inc. (PEPG) Form SCHEDULE 13D/A — Nov 17, 2026

$PEPGForm SCHEDULE 13D/AFiled Nov 17, 2026, 4:10 PM ET0001346824-26-000301Original filing

RA Capital and its principals filed a Schedule 13D/A disclosing that its Healthcare Fund purchased 8,625,000 PepGen shares at $5.00 per share on November 13, 2026, for a total of $43.125 million, in PepGen's 25 million-share public offering. The purchase lifts RA Capital's aggregate beneficial ownership to 28,742,212 shares, or 30.5% of PepGen's common stock, based on 69,261,282 shares outstanding plus offering shares.

Key figures

Shares Outstanding
69261282
Percent owned
30.5%
Offering shares issued
25000000
Aggregate purchase price
$43.125 million
Purchase price per share
$5.00
Shares purchased in offering
8625000

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    PepGen Inc. (PEPG) Form SCHEDULE 13D/A — Nov 17, 2026: AI Analysis | Signal8